Search in:   Search
spacer

Egypt Pharmaceuticals & Healthcare Report Q2 2013

Published by Business Monitor International on Mar 4, 2013 , 105 pages
PDF - Download Now with 3 Quarterly Updates format - Delivered by download


Description
BMI View: Geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Egypt may be a favourable strategy for any multinational drugmaker. However,despite our forecast for steady growth in theEgyptianpharmaceutical market,it is vitalthat companiesrecognise the risks. Downside risks to our forecast, in addition to the country's state of political and economic flux,are:the patent cliff, pricing, higher domestic drug production output and adiversificationofdrugs availableat competitive prices in the generic drug sector.



REPORT TOOLSarrow
Share This Report
Request More Information
Printable Brochure
ORDERINGarrow
Ordering reports couldn't be easier. Select the license for your needs, click Order Now, and complete our streamlined checkout process. We accept major credit cards, wire/bank transfers, and checks.

MC, Visa, AMEX, Diners, Discovery, JCB

PUBLISHERarrow
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.\n\nBMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including Daily Alerts, monthly regional Insights, and in-depth quarterly Country Forecast Reports.
Publisher Details


Privacy Policy | Terms of Use | Sitemap

Copyright © 2012 Fast Market Research, Inc.